comprehensive -WSS

comprehensive

author：leisure time 2025-09-27 19:37:21 - browse：94

Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Bernie Sanders is gearing up to subpoena pharma CEOs

explore

WSS

Philips to halt sales of sleep apnea machines in U.S.

Biogen walks away from Aduhelm, years after polarizing approval

Novartis develops a rapidly manufactured CAR

Statins reduce cardiovascular risk in people living with HIV

Investment in vaccine development is lagging, report finds

Why Medicare shouldn’t cover every FDA

entertainment

comprehensive

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medicare Advantage insurers face 0.2% cut to 2025 payments

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Humana’s losses in Medicare Advantage tank its stock

Heart attack and stroke risk calculators need revising

Severe heat forecast: Where scorching temperatures will persist over the next week

The cancer drug shortage isn’t new — and neither are the solutions

Why you shouldn’t ask, “What country has the best health care?”

Medicare proposal to cover medical devices draws a mixed reaction

10 reasons why health care startups fail

explore

Merck, Johnson & Johnson CEOs will testify on high drug prices

Severe heat forecast: Where scorching temperatures will persist over the next week

Men with early prostate cancer can safely opt out of treatment

Novartis develops a rapidly manufactured CAR

New requirements coming in 2024 for Americans traveling to Europe

Burning questions about Delta and the next phase of the Covid pandemic

explore

hotspot

hotspot

hotspot